— Know what they know.
Not Investment Advice

RLLVF OTC

Relevium Technologies Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -80.8% 5Y: -95.2%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 38 · $2.0M mcap · 319M float · 0.0000% daily turnover

Income Trends

Revenue
$914K -69.3% ▼
Gross Profit
$414K -65.3% ▼
Operating Income
-$1M +46.8% ▲
Net Income
-$5M +22.6% ▲
EPS (Diluted)
$-0.03 +30.2% ▲
EBITDA
-$5M +1.2% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021
Revenue$3M$914K
YoY Growth+0.0%-69.3%
Cost of Revenue$2M$499K
Gross Profit$1M$414K
Gross Margin40.2%45.4%
R&D Expenses$0$0
SG&A Expenses$4M$2M
Operating Expenses$1M$2M
Operating Income-$3M-$1M
Operating Margin-93.2%-161.5%
Interest Expense$567K$751K
Income Before Tax-$7M-$5M
Tax Expense$0$0
Net Income-$7M-$5M
Net Margin-233.1%-587.6%
EPS (Diluted)$-0.04$-0.03
EBITDA-$6M-$5M
Shares Outstanding187M207M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms